Share on PinterestAlzheimer’s drug Leqembi is linked to steady or improved outcomes in additional than three-quarters of contributors. Picture credit score: Getty Photos/ Tatiana Maksimova An actual-world examine discovered that almost all sufferers receiving the anti-amyloid remedy Leqembi (lecanemab) remained clinically steady after 17 months, with 75.9% remaining on the identical stage and 6.6% enhancing... Read More










:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-1248002371-dbd3b7e99663437a83b82d45cd84ea8a.jpeg?w=160&resize=160,100&ssl=1)

:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)




Recent Comments